Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

ues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to Amgen's business.  Unless otherwise noted, Amgen is providing this information as of August 25, 2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects.  Risks and uncertainties include whether the proposed transaction described in this press release can be completed in a timely manner, and whether the anticipated benefits of the proposed transaction can be achieved.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for Amgen to complete c
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/56cq5n/motion_simulation ) has ... Market by Type (Hydraulic and Actuator), Degree of ... Application (Automotive, Defense, Entertainment, Healthcare, Mining, R&D, Sports, ... " report to their offering. ... enough for commercial use, and thus its market ...
(Date:6/2/2015)...  Nektar Therapeutics (NASDAQ: NKTR ) and The ... a research collaboration that includes a Phase 1/2 clinical ... preferentially stimulate production of CD8-positive T cells, which are ... which is also known as the Interleukin-2 receptor beta ... to increase proliferation of these effector T cells. 1 ...
(Date:6/2/2015)... , June 2, 2015 Northstar ... first television and multi-media commercial advertisement, which it ... to promote SNORenz®, the company,s top selling product. ... the company,s past success with television advertising. Previous ... but this, more modern version takes an entertainment-oriented ...
Breaking Medicine Technology:Global Motion Simulation Market 2015-2020 - Type, Degree of Freedom, Application, and Regional Analysis 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2
... Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a ... company will actively participate at the Save A Leg, ... in Orlando tomorrow, October 8. , In addition to exhibiting its ... a workshop entitled " The ...
... ACCESS PHARMACEUTICALS, INC . (OTC ... agreement with iMedicor (OTC Bulletin Board: VMCI) for the North ... rinse for the management of oral mucositis and stomatitis caused ... System application, initial introduction of MuGard to the 216,000 selected ...
Cached Medicine Technology:Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference 2Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference 3Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 2Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 3Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 4
(Date:6/2/2015)... OR (PRWEB) June 02, 2015 With ... dry in most parts of the United States, people ... conditioned rooms. Despite the obvious benefits of air conditioning, ... effects, including dry eye, dehydration and allergic reactions. Fresh ... Hour™ Power of Water® radio show, will discuss the ...
(Date:6/2/2015)... Bank, New Jersey (PRWEB) June 02, 2015 ... New Jersey’s largest nonprofit provider of home health ... appointment of its President and CEO, Steve Landers, ... America's (VNAA) Board of Directors. , VNAA ... that supports, promotes and advances mission driven, nonprofit ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Mercy Health ... serving Ohio and Kentucky – has devoted the seventh ... videos to skin cancer prevention. One in five Americans ... on Mercy Health’s YouTube channel, a Mercy Health expert ... are the main causes of skin cancer? , ...
(Date:6/2/2015)... 2015 First Choice Emergency Room ... in the United States, named Kenneth Alan Totz, D.O.as ... Road facility. , “We are pleased to announce ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director ... received his undergraduate degree from St. Edwards University in ...
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 ... Iowa community, has granted $70,000 to the UNMC to support ... NFL Kicker Billy Cundiff, a member of the Colleen’s Dream ... grant was the biggest to date for Colleen’s Dream ... Dr. Wang in Omaha. , “Dr. Wang is a rising ...
Breaking Medicine News(10 mins):Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 2Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 3Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Video provides helpful information about skin cancer prevention 2Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3
... participated in a cardiac-rehab program after a heart attack had ... the same age and sex who had not had a ... that occurred among patients in their study were due to ... involved about 1,800 patients. Nearly 60 percent participated in cardiac ...
... substantial morbidity and mortality and the incidence of MRSA ... to prevent the spread of MRSA including better hand ... the detection and isolation of infected patients. ... were done looking at reducing the spread of MRSA. ...
... reveals women suffering from extremely low body fat whether ... may benefit from treatment with the appetite-and-weight-regulation hormone ... in treating some instances of infertility. ,Leptin is ... stream, where it then travels to the brain and ...
... point to seek mental counseling. Experts say diabetics under ... because of unhealthy habits they implement to deal with ... showed nearly 13 percent of respondents experience psychological symptoms ... under mental distress are more likely than non-stressed diabetics ...
... recent study, a poor oral health diagnosis was a ... such as // high levels of fibrinogen (a clotting ... ,Researchers compared the oral health data of 256 ... characteristics. Results of the study show the strongest predictor ...
... new study shows consuming foods or supplements containing the omega-3 ... to avoid Alzheimer’s disease // even if you carry a ... study researchers first bred mice to carry the gene known ... various environmental factors affecting the symptoms were studied but the ...
Cached Medicine News:
Straight shafts with teeth and 5 mm tying platform. Wide serrated handle with polished finish. Teeth: 0.3 mm. Manufactured in titanium....
Serrated, 10 mm tips angled 90 degrees. Serrated cross action handle with polished finish....
Ergotec Vetriretinal Instrument System. Fine angled tips (3 mm). 20 gauge shaft length with black tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. 2 mm pointed black tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Medicine Products: